Researches

South Egypt Cancer Institute

Assiut University

# Title Department Research Member Research Year
131 Concurrent capecitabine with external beam radiotherapy versus radiotherapy alone in painful bone metastasis of breast cancer origin Department of Radiotherapy and Nuclear medicine Dr. Ayat allah Ali yousseif 2021
132 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Medical Oncology Dr. Salah Mabrouk Khallaf Abd Rabou 2021
133 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Department of Clinical Pathology Prof. Douaa Mohamed Sayed Hussein 2021
134 Ewing sarcoma outcomes in a country with limited resources: Egypt as an example Department of Medical Oncology Dr. Ahmed Mubarak Hefni Ismail 2021
135 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Department of Clinical Pathology Dr. Iman Hassan Ahmed Hamada 2021
136 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Dr. Murad Aly Jabir Ahmed 2021
137 Relation of Estrogen Receptor Expression to Recurrence and Survival in Early and Locally Advanced Breast Cancer
 		Department of Medical Oncology Dr. Mayada Fawzy Sedik Farghaly 2021
138 Gastric signet ring cell carcinoma, does it confer a worse prognosis and treatment outcome Department of Radiotherapy and Nuclear medicine Dr. Doaa Mohamed Fouad Mahmoud 2021
139 Interleukin-10: A Potential Prognostic Marker in Patients with Newly Diagnosed Multiple Myeloma Department of Clinical Pathology Prof. Rania / Mohamed Mohamed / Bakri / El-Aton 2021
140 Clinical Outcome of Pediatric Acute Myeloid Leukemia Treated at South Egypt Cancer Institute, Assiut University, Egypt Department of Pediatric Oncology Dr. Ahmed Mohammed Morsy Hassan 2021